海南海药
(000566)
| 流通市值：66.69亿 | | | 总市值：74.21亿 |
| 流通股本：11.66亿 | | | 总股本：12.97亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 340,612,253.65 | 303,738,729.5 | 329,624,399.72 | 272,741,302.25 |
| 结算备付金 | - | - | 0 | - |
| 拆出资金 | - | - | 0 | - |
| 交易性金融资产 | 192,194,809.9 | 192,054,532.09 | 192,060,000 | 559,364,227.05 |
| 衍生金融资产 | - | - | 0 | - |
| 应收票据及应收账款 | 389,952,930 | 377,634,263.76 | 401,218,260.65 | 409,706,262.43 |
| 其中：应收票据 | 18,983,016.69 | 31,568,805.62 | 60,478,899.49 | 60,871,413.23 |
| 应收账款 | 370,969,913.31 | 346,065,458.14 | 340,739,361.16 | 348,834,849.2 |
| 应收款项融资 | 6,979,538.81 | 8,909,825.4 | 8,660,945.05 | 8,788,999.7 |
| 预付款项 | 12,583,578.63 | 11,973,202.92 | 11,223,965.3 | 21,683,910.16 |
| 应收保费 | - | - | 0 | - |
| 应收分保账款 | - | - | 0 | - |
| 应收分保合同准备金 | - | - | 0 | - |
| 其他应收款合计 | 123,256,736.63 | 54,187,592.54 | 57,980,478.42 | 464,036,127.22 |
| 其中:应收利息 | - | - | 0 | - |
| 应收股利 | - | - | 0 | - |
| 买入返售金融资产 | - | - | 0 | - |
| 存货 | 320,266,299.27 | 375,296,222.98 | 375,432,144.11 | 449,920,750.59 |
| 合同资产 | 0 | - | 0 | - |
| 一年内到期的非流动资产 | - | - | 0 | - |
| 其他流动资产 | 24,671,309.01 | 31,410,936.48 | 25,555,270.01 | 28,382,854.67 |
| 流动资产合计 | 1,410,517,455.9 | 1,355,205,305.67 | 1,401,755,463.26 | 2,214,624,434.07 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | - | - | 0 | - |
| 债权投资 | - | - | 0 | - |
| 其他债权投资 | - | - | 0 | - |
| 长期应收款 | - | - | 0 | - |
| 长期股权投资 | 423,312,350.87 | 430,754,662.6 | 429,519,914.71 | 616,016,326.43 |
| 其他权益工具投资 | 326,030,000 | 326,030,000 | 326,030,000 | 331,188,810 |
| 其他非流动金融资产 | - | - | 0 | - |
| 投资性房地产 | 216,988,166.15 | 221,117,865.68 | 222,809,803.83 | 223,658,038.86 |
| 固定资产 | 1,884,541,688.79 | 1,688,164,160.19 | 1,711,107,600.85 | 1,403,554,107.88 |
| 在建工程 | 475,739,665.79 | 781,300,230.64 | 776,248,202.36 | 1,128,145,904.25 |
| 生产性生物资产 | - | - | 0 | - |
| 油气资产 | - | - | 0 | - |
| 使用权资产 | 77,511.08 | 155,022.29 | 232,533.47 | 310,044.68 |
| 无形资产 | 725,594,799.14 | 727,304,234.84 | 711,025,826.63 | 698,578,252.16 |
| 开发支出 | 214,674,018.55 | 219,313,406.98 | 228,106,040.78 | 257,546,434.29 |
| 商誉 | 102,314,083.42 | 102,314,083.42 | 102,314,083.42 | 218,243,863.49 |
| 长期待摊费用 | 31,360,612.57 | 32,700,729.39 | 34,218,781.96 | 22,046,536.14 |
| 递延所得税资产 | 102,612,963.62 | 102,615,830.02 | 102,633,380.69 | 144,225,439.51 |
| 其他非流动资产 | 65,830,326.56 | 66,318,445.5 | 67,526,867.73 | 30,280,727.2 |
| 非流动资产合计 | 4,569,076,186.54 | 4,698,088,671.55 | 4,711,773,036.43 | 5,073,794,484.89 |
| 资产总计 | 5,979,593,642.44 | 6,053,293,977.22 | 6,113,528,499.69 | 7,288,418,918.96 |
| 流动负债: | | | | |
| 短期借款 | 1,128,000,000 | 1,571,000,000 | 1,662,430,227.35 | 1,450,340,118.94 |
| 向中央银行借款 | - | - | 0 | - |
| 吸收存款及同业存放 | - | - | 0 | - |
| 拆入资金 | - | - | 0 | - |
| 交易性金融负债 | - | - | 0 | - |
| 衍生金融负债 | - | - | 0 | - |
| 应付票据及应付账款 | 566,401,990.27 | 599,675,482.62 | 500,365,801.37 | 464,345,686.32 |
| 其中：应付票据 | 166,911,306.67 | 186,203,316.67 | 98,050,520 | 105,778,394.73 |
| 应付账款 | 399,490,683.6 | 413,472,165.95 | 402,315,281.37 | 358,567,291.59 |
| 预收款项 | 247,184.96 | 589,869.55 | 1,092,927.62 | 356,393.54 |
| 合同负债 | 17,242,890.46 | 26,034,725.5 | 29,580,091.44 | 19,526,532.4 |
| 卖出回购金融资产款 | - | - | 0 | - |
| 应付手续费及佣金 | - | - | 0 | - |
| 应付职工薪酬 | 20,896,432.07 | 17,751,668.11 | 25,261,125.67 | 16,990,980.93 |
| 应交税费 | 29,104,319.59 | 14,715,664.85 | 15,762,969.17 | 16,738,401.6 |
| 其他应付款合计 | 1,853,448,398.07 | 1,314,744,266.03 | 1,079,783,171.9 | 759,584,878.18 |
| 其中:应付利息 | 5,467,146.57 | 5,467,146.57 | 5,467,146.57 | 6,003,146.57 |
| 应付股利 | 3,975,170.8 | 3,975,170.8 | 3,975,170.8 | 3,975,170.8 |
| 应付分保账款 | - | - | 0 | - |
| 保险合同准备金 | - | - | 0 | - |
| 代理买卖证券款 | - | - | 0 | - |
| 代理承销证券款 | - | - | 0 | - |
| 一年内到期的非流动负债 | 703,573,408.19 | 689,095,740.29 | 925,094,301.42 | 826,093,109.61 |
| 其他流动负债 | 17,747,826.78 | 32,451,311.56 | 59,761,025.4 | 59,852,446.42 |
| 流动负债合计 | 4,336,662,450.39 | 4,266,058,728.51 | 4,299,131,641.34 | 3,613,828,547.94 |
| 非流动负债: | | | | |
| 长期借款 | 955,536,676.3 | 958,157,688 | 864,499,038 | 1,143,139,185 |
| 应付债券 | - | - | 0 | - |
| 优先股 | - | - | 0 | - |
| 永续债 | - | - | 0 | - |
| 租赁负债 | 0 | - | 0 | 0 |
| 长期应付款 | 70,872,569.3 | 113,928,199.11 | 157,786,123.53 | 200,462,926.47 |
| 长期应付职工薪酬 | - | - | 0 | - |
| 预计负债 | 153,260.22 | 4,611,171.45 | 4,611,171.45 | 238,918,680.35 |
| 递延收益 | 81,766,732.92 | 79,725,641.16 | 80,249,081.83 | 77,556,064.62 |
| 递延所得税负债 | 23,851,222.43 | 23,862,849.11 | 23,874,475.79 | 35,176,999.23 |
| 其他非流动负债 | 93,000,000 | 93,000,000 | 93,000,000 | 93,000,000 |
| 非流动负债合计 | 1,225,180,461.17 | 1,273,285,548.83 | 1,224,019,890.6 | 1,788,253,855.67 |
| 负债合计 | 5,561,842,911.56 | 5,539,344,277.34 | 5,523,151,531.94 | 5,402,082,403.61 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,297,365,126 | 1,297,365,126 | 1,297,365,126 | 1,297,365,126 |
| 其他权益工具 | - | - | 0 | - |
| 优先股 | - | - | 0 | - |
| 永续债 | - | - | 0 | - |
| 资本公积 | 2,798,180,337.92 | 2,798,180,337.92 | 2,798,180,337.92 | 2,808,402,778.99 |
| 减:库存股 | - | - | 0 | - |
| 其他综合收益 | -32,656,371.79 | -32,194,026.34 | -32,051,676.15 | -30,661,843.86 |
| 专项储备 | - | - | 0 | - |
| 盈余公积 | 90,919,423.22 | 90,919,423.22 | 90,919,423.22 | 90,919,423.22 |
| 一般风险准备 | - | - | 0 | - |
| 未分配利润 | -3,787,433,334.43 | -3,697,491,682.71 | -3,629,126,228.15 | -2,399,114,243.69 |
| 归属于母公司股东权益合计 | 366,375,180.92 | 456,779,178.09 | 525,286,982.84 | 1,766,911,240.66 |
| 少数股东权益 | 51,375,549.96 | 57,170,521.79 | 65,089,984.91 | 119,425,274.69 |
| 股东权益合计 | 417,750,730.88 | 513,949,699.88 | 590,376,967.75 | 1,886,336,515.35 |
| 负债和股东权益合计 | 5,979,593,642.44 | 6,053,293,977.22 | 6,113,528,499.69 | 7,288,418,918.96 |
| 公告日期 | 2025-08-27 | 2025-04-30 | 2025-04-12 | 2024-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |